Effects of mood stabilizers on the disruption of prepulse inhibition induced by apomorphine or dizocilpine in mice

European Journal of Pharmacology

Volumn 553, Issue 1-3, 2006, Pages 157-162

  Umeda, Kenta ^a,b   Suemaru, Katsuya ^c   Todo, Nobuko ^b   Egashira, Nobuaki ^a   Mishima, Kenichi ^a   Iwasaki, Katsunori ^a   Fujiwara, Michihiro ^a   Araki, Hiroaki ^c  

^a FUKUOKA UNIVERSITY   (Japan)

^b Minami Matsuyama Hospital   (Japan)

^c EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Apomorphine; Carbamazepine; Dizocilpine; Lithium; Mood stabilizers; Prepulse inhibition; Valproate

Indexed keywords

APOMORPHINE; CARBAMAZEPINE; DIZOCILPINE; LITHIUM CARBONATE; MOOD STABILIZER; VALPROIC ACID;

ACOUSTIC REFLEX; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DOPAMINERGIC SYSTEM; DRUG EFFECT; MALE; MOUSE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; STARTLE REFLEX;

AFFECT; ANIMALS; ANTIMANIC AGENTS; APOMORPHINE; CARBAMAZEPINE; DIZOCILPINE MALEATE; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID AGONISTS; GABA AGENTS; LITHIUM CARBONATE; MALE; MICE; RECEPTORS, N-METHYL-D-ASPARTATE; STARTLE REACTION; VALPROIC ACID;

EID: 33751198705     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.09.050     Document Type: Article

References (27)

1. Ahmad S., Fowler L.J., and Whitton P.S. Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids. Epilepsy Res. 63 (2005) 141-149
2. Arban R., Maraia G., Brackenborough K., Winyard L., Wilson A., Gerrard P., and Large C. Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania. Behav. Brain Res. 158 (2005) 123-132
3. Berridge M.J., Downes C.P., and Hanley M.R. Neural and developmental actions of lithium: a unifying hypothesis. Cell 59 (1989) 411-419
4. Braff D.L., and Geyer M.A. Sensorimotor gating and schizophrenia. Human and animal model studies. Arch. Gen. Psychiatry 47 (1990) 181-188
5. Brody S.A., Geyer M.A., and Large C.H. Lamotrigine prevents ketamine but not amphetamine-induced deficits in prepulse inhibition in mice. Psychopharmacology (Berlin) 169 (2003) 240-246
6. Bubenikova V., Votava M., Horacek J., Palenicek T., and Dockery C. The effect of zotepine, risperidone, clozapine and olanzapine on MK-801-disrupted sensorimotor gating. Pharmacol. Biochem. Behav. 80 (2005) 591-596
7. Canal N.M., Gourevitch R., and Sandner G. Non-monotonic dependency of PPI on temporal parameters: differential alteration by ketamine and MK-801 as opposed to apomorphine and DOI. Psychopharmacology (Berlin) 156 (2001) 169-176
8. Castellanos F.X., Fine E.J., Kaysen D.L., Marsh W.L., Rapoport J.L., and Hallett M. Sensorimotor gating in boys with Tourette's Syndrome and ADHD: preliminary results. Biol. Psychiatry 39 (1996) 33-41
9. Davis M., Mansbach R.S., Swerdlow N.R., Campeau S., Braff D.L., and Geyer M.A. Apomorphine disrupts the inhibition of acoustic startle induced by weak prepulses in rats. Psychopharmacology (Berlin) 102 (1990) 1-4
10. Dixon J.F., and Hokin L.E. The antibipolar drug valproate mimics lithium in stimulating glutamate release and inositol 1,4,5-trisphosphate accumulation in brain cortex slices but not accumulation of inositol monophosphates and bisphosphates. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 4757-4760
11. Johannessen C.U. Mechanisms of action of valproate: a commentatory. Neurochem. Int. 37 (2000) 103-110
12. Klein P.S., and Melton D.A. A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci U. S. A. 93 (1996) 8455-8459
13. Kodsi M.H., and Swerdlow N.R. Ventral pallidal GABA-A receptors regulate prepulse inhibition of acoustic startle. Brain Res. 684 (1995) 26-35
14. Ludewig K., and Vollenweider F.X. Impaired sensorimotor gating in schizophrenia with deficit and with nondeficit syndrome. Swiss Med. Wkly. 132 (2002) 159-165
15. Mansbach R.S., Geyer M.A., and Braff D.L. Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology (Berlin) 94 (1988) 507-514
16. Murakami T., Okada M., Kawata Y., Zhu G., Kamata A., and Kaneko S. Determination of effects of antiepileptic drugs on SNAREs-mediated hippocampal monoamine release using in vivo microdialysis. Br. J. Pharmacol. 134 (2001) 507-520
17. Nonaka S., Hough C.J., and Chuang D.M. Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-d-aspartate receptor-mediated calcium influx. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 2642-2647
18. Okada K., Oishi R., and Saeki K. Inhibition by antimanic drugs of hyperactivity induced by methamphetamine-chlordiazepoxide mixture in mice. Pharmacol. Biochem. Behav. 35 (1990) 897-901
19. Okada M., Hirano T., Mizuno K., Chiba T., Kawata Y., Kiryu K., Wada K., Tasaki H., and Kaneko S. Biphasic effects of carbamazepine on the dopaminergic system in rat striatum and hippocampus. Epilepsy Res. 28 (1997) 143-153
20. O'Neill H.C., Schmitt M.P., and Stevens K.E. Lithium alters measures of auditory gating in two strains of mice. Biol. Psychiatry 54 (2003) 847-853
21. Ong J.C., Brody S.A., Large C.H., and Geyer M.A. An investigation of the efficacy of mood stabilizers in rodent models of prepulse inhibition. J. Pharmacol. Exp. Ther. 315 (2005) 1163-1171
22. Swerdlow N.R., Benbow C.H., Zisook S., Geyer M.A., and Braff D.L. A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder. Biol. Psychiatry 33 (1993) 298-301
23. Swerdlow N.R., Braff D.L., Taaid N., and Geyer M.A. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch. Gen. Psychiatry 51 (1994) 139-154
24. Swerdlow N.R., Paulsen J., Braff D.L., Butters N., Geyer M.A., and Swenson M.R. Impaired prepulse inhibition of acoustic and tactile startle in patients with Huntington's Disease. J. Neurol. Neurosurg. Psychiatry 58 (1995) 192-200
25. Tam W.C., Sewell K.W., and Deng H.C. Information processing in schizophrenia and bipolar disorder: a discriminant analysis. J. Nerv. Ment. Dis. 186 (1998) 597-603
26. Tremolizzo L., Carboni G., Ruzicka W.B., Mitchell C.P., Sugaya I., Tueting P., Sharma R., Grayson D.R., Costa E., and Guidotti A. An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 17095-17100
27. Tremolizzo L., Doueiri M.S., Dong E., Grayson D.R., Davis J., Pinna G., Tueting P., Rodriguez-Menendez V., Costa E., and Guidotti A. Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice. Biol. Psychiatry 57 (2005) 500-509